The Vaccination for Life initiative is an initiative that aims to raise awareness about the importance of vaccination and the role of vaccination in preventing some infectious diseases. This website is provided in cooperation between GlaxoSmithKline - Egypt and the Egyptian Pediatric Society.
GlaxoSmithKline (GSK) is one of the world’s leading vaccine manufacturers.
GSK is devoted to discovering new vaccines that are cost-effective, convenient, and designed to prevent infections that cause serious medical problems in both the developed and developing world.
In 2006, GSK distributed 1.1 billion doses of vaccines, 75% of which went to the developing world.
Egyptian Pediatric Society2
A dynamic organization that believes in the inherent worth of all children since they are our most enduring, precious and vulnerable legacy.
Providing the highest quality health care to enable and empower them to achieve optimum health physically, mentally & psychologically.
Contact Us
GlaxoSmithKline S.A.E. Building no. 46, Block (J), Fifth District, Boomerang, New Cairo, Egypt. Tel.: +202 26185000 or through email: ae.egypt@gsk.com
©2025 GSK group of companies or its licensor. All rights reserved.
Privacy Policy | Cookies Policy | Disclaimer
THIS WEBSITE IS ONLY FOR RESIDENTS OF EGYPT. A public awareness initiative by GlaxoSmithKline S.A.E. Building no. 46, Block (J), Fifth District, Boomerang, New Cairo, Egypt.Information appearing in this material is for general awareness only. Nothing contained in this material constitutes medical advice. Please consult your doctor for medical advice or any question or concern you may have regarding your condition. Please consult your doctor/child’s Paediatrician for the complete list of vaccine-preventable diseases and the complete vaccination schedule for each disease. The doctor, unless otherwise clearly indicated and if any, shown in this material is for illustration purpose only and is a professional model. All scientific information is validated. GSK does not recommend, endorse or accept liability for sites controlled by a third party.
CL code: NP-EG-VX-WCNT-250001, DoP: Apr 2025
EDA Approval No.: SF0472OA3923/052025 Invalidation Date: 13/05/2026
Kindly report any violated online promotional, educational and awareness material not having this message to The General administration for Regulation of Marketing & Advertising Materials at: www.edaegypt.gov.eg